[{"Assets_0_FY_USD":11734500000.0,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":2195100000.0,"NetIncomeLoss_1_FY_USD":820400000.0,"NetIncomeLoss_4_FY_USD":2444400000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":107900000.0,"StockholdersEquity_0_FY_USD":8757300000.0,"EarningsPerShareBasic_1_FY_USD":7.58,"EarningsPerShareBasic_4_FY_USD":22.65,"Ticker":"REGN","CIK":"872589","name":"REGENERON PHARMACEUTICALS INC","OfficialName":"Regeneron Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"77738004554.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190207"}]